No comment on the PR other than to say it has definitely ramped up and it is working. The more people hear about it the better it seems. At least now there is a basic platform of updated information out there that shareholders can make informed decisions on rather than the prior 12 months where I felt that we were under informed.
That Bioshares article really frustrates me - how you can credit the SP movement to a $750k research grant mid Dec when there was SCREAMING validation in a payment nearly 4x that directly to PYC from Genentech also in Dec is beyond me.
I know which one made me start buying.
Analyst Reports, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $874.8M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 18.5¢ | $331.8K | 1.731M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 711601 | 7 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |